05:51 PM EST, 12/06/2024 (MT Newswires) -- Christopher Gibson, Director, Chief Executive Officer, on December 04, 2024, sold 40,000 shares in Recursion Pharmaceuticals ( RXRX ) for $285,600. Following the Form 4 filing with the SEC, Gibson has control over a total of 736,633 shares of the company, with 736,633 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1601830/000160183024000234/xslF345X05/wk-form4_1733525191.xml